Simplifying Global Compliance
Phase IV Trials Mandated by FDAAAWith Great Power Comes Great Responsibility
First, complying with these new requirements will not be easy — because there is no one-size-fits-all guidance to help a particular drug or drug class prepare for the studies. Even the FDA admits it lacks the expertise to design the studies … so it will turn to its advisory committees to address the particulars of each product and make specific recommendations.
Audio CD/Transcript - March 4, 2010
The Audio CD/Transcript will be shipped the week of March 29, 2010.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing